Health & Biotech Greg Hunt revives one-stop-shop idea for Aussie clinical trials July 7, 2020 Health Minister Greg Hunt has revived a long-standing plan to turn Australia into a "one stop shop" for clinical trials,… Nyrada one step closer to cholesterol pill, shares surge July 6, 2020 Nyrada (ASX: NYR) has received "encouraging" results from a lab-based cholesterol-lowering study, for the drug it hopes to use to… The watchlist of likely losers from Victoria re-entering lockdown July 6, 2020 Domestic travel companies, financial services, non-discretionary retailers, real estate investment trusts (REITs), and toll road operator Transurban (ASX:TCL) are on… Dr Boreham’s Crucible: Mesoblast within months of 3 major trial results, key regulatory decision July 6, 2020 The world’s biggest listed pure-play stem cell developer has a busy slate of clinical work, notably in therapies for advanced… MGC Pharma selected for WHO COVID taskforce, shares jump July 2, 2020 The World Health Organisation (WHO) has selected MGC Pharma (ASX:MGC) for its COVID-19 taskforce. The news impressed investors, which pushed… Osteopore cracks billion dollar US bone healing market, shares surge July 2, 2020 Special Report: Osteopore breaks into billion-dollar US bone healing market with brand new deal. Osteopore (ASX:OSX) has breached the massive… Bod makes $2.5m from Aussie pot buyers in the June quarter alone July 2, 2020 Money is coming in for marijuana companies, as Bod Australia (ASX:BOD) leads the total today with news of a $2.5m… Strong interest for Compass Cannabis’ $2m cap raise kick-off July 2, 2020 Special Report: Compass Cannabis launches its equity crowdfunded cap raise today on the back of strong interest from professional and… MedAdvisor eyes off US health insurance market with new distribution deal July 1, 2020 Medtech company MedAdvisor (ASX:MDR) had some deal-flow this morning, announcing a partnership with NASDAQ-listed HMS Holdings Corp. The three-year agreement… COVID-19 adds $9bn to top four ASX health stocks July 1, 2020 That COVID-19 has been wonderful for pharmaceutical companies is not in doubt, but it hasn't been quite so good for… Next» « Previous